NEW YORK (GenomeWeb) – Nanosphere reported after the close of the market on Wednesday that its revenues rose 42 percent year over year, driven by a sharp uptick in consumables sales.

However, Nanosphere fell short of analysts' consensus estimates and lowered its guidance for the year. Investors drove shares of the firm down 29 percent to $1.01 in Thursday morning trade on the Nasdaq.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.